Literature DB >> 9314019

Diabetes management in special situations.

I B Hirsch1, D S Paauw.   

Abstract

Clinicians are frequently required to manage situations for which few data are available in the literature. Medical therapies for these situations are frequently based on graduate and postgraduate training, community standards, and personal experience. For individuals with diabetes, this would include perioperative diabetes management, the management of diabetes while discontinuing an insulin infusion, and the management of diabetes during treatment with glucocorticoids and TPN. Clinicians may disagree with some of the recommendations for these four situations, and implementation of these suggestions may not be possible at all hospitals. The therapies described herein are based on the pathophysiology of the respective situation and the pharmacokinetic and pharmacodynamic properties of available medications, particularly insulin. The introduction of new insulin analogues and agents to treat insulin resistance may improve our ability to treat diabetes in special situations. Future investigations should focus on how to best use these tools during critical times.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9314019     DOI: 10.1016/s0889-8529(05)70271-1

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  8 in total

1.  Novel views on new-onset diabetes after transplantation: development, prevention and treatment.

Authors:  Manfred Hecking; Johannes Werzowa; Michael Haidinger; Walter H Hörl; Julio Pascual; Klemens Budde; Fu L Luan; Akinlolu Ojo; Aiko P J de Vries; Esteban Porrini; Giovanni Pacini; Friedrich K Port; Adnan Sharif; Marcus D Säemann
Journal:  Nephrol Dial Transplant       Date:  2013-01-17       Impact factor: 5.992

Review 2.  Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.

Authors:  J A P Da Silva; J W G Jacobs; J R Kirwan; M Boers; K G Saag; L B S Inês; E J P de Koning; F Buttgereit; M Cutolo; H Capell; R Rau; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

Review 3.  Inpatient diabetology. The new frontier.

Authors:  Nicolas N Abourizk; Chaula K Vora; Parveen K Verma
Journal:  J Gen Intern Med       Date:  2004-05       Impact factor: 5.128

Review 4.  Steroid hyperglycemia: Prevalence, early detection and therapeutic recommendations: A narrative review.

Authors:  Héctor Eloy Tamez-Pérez; Dania Lizet Quintanilla-Flores; René Rodríguez-Gutiérrez; José Gerardo González-González; Alejandra Lorena Tamez-Peña
Journal:  World J Diabetes       Date:  2015-07-25

5.  Pharmacodynamics of glucose regulation by methylprednisolone. I. Adrenalectomized rats.

Authors:  Jin Y Jin; William J Jusko
Journal:  Biopharm Drug Dispos       Date:  2009-01       Impact factor: 1.627

6.  Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine.

Authors:  Tomohiro Kaneko; Momoko Arai; Mariko Ikeda; Megumi Morita; Yoko Watanabe; Akio Hirama; Akira Shimizu; Shuichi Tsuruoka
Journal:  Int Urol Nephrol       Date:  2015-10-03       Impact factor: 2.370

7.  Dulaglutide improves glucocorticoid-induced hyperglycemia in inpatient care and reduces dose and injection frequency of insulin.

Authors:  Hiroyuki Uchinuma; Masashi Ichijo; Noriyuki Harima; Kyoichiro Tsuchiya
Journal:  BMC Endocr Disord       Date:  2020-05-07       Impact factor: 2.763

8.  Steroid-induced diabetes: is it just unmasking of type 2 diabetes?

Authors:  Lisa R Simmons; Lynda Molyneaux; Dennis K Yue; Elizabeth L Chua
Journal:  ISRN Endocrinol       Date:  2012-07-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.